Outset Medical (OM)10% owner bought ~$64K

~$64K

Approx. value · 17K sh @ $3.88

2.76M

Holds after · shares reported

Traded

Oct 2, 2026

Filed

Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 17, 2026Insider · 3 peopleInsiders: 3 sales (~$47K)
3. Aug 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 27, 2026, John Brottem informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as General Counsel, effective September 11, 2026, to pursue other professional opportunities.”
4. Oct 1, 2026Insider · First insider buy since Nov 202210% owner purchased ~$806K of OM shares in the open market
5. Oct 2, 2026 · this disclosureInsider10% owner purchased ~$64K of OM shares in the open market

What came next

1. Oct 6, 20265% stakeBML Investment Partners, L.P. reported a passive stake (13G) of 14.7%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Outset Medical

For Outset Medical, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OM page.

Other recent filings by Leonard Braden Michael, 10% owner

• SEC Form 4 at Outset Medical (OM)Oct 6, 2026
• SEC Form 4 at An2 Therapeutics (ANTX)Jun 16, 2025
• SEC Form 4 at An2 Therapeutics (ANTX)May 30, 2025
• SEC Form 4 at An2 Therapeutics (ANTX)May 30, 2025
• SEC Form 4 at An2 Therapeutics (ANTX)May 30, 2025

The full history of Leonard Braden Michael, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Outset Medical

• SEC Form 4Oct 6, 2026
• SEC Form 4Aug 19, 2026
• SEC Form 4Aug 19, 2026
• SEC Form 4Aug 19, 2026
• SEC Form 4Jun 6, 2026
• SEC Form 4May 20, 2026

Everything OQRO holds on this company is on its OM page.